Anika Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Anika Therapeutics (ANIK) Tops Q2 EPS by 28c
July 24, 2019 4:09 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.67, $0.28 better than the analyst estimate of $0.39. Revenue for the quarter came in at $30.4 million versus the consensus estimate of $27.5 million.
Anika delivered strong earnings and cash flow in the second quarter, while we continued our... More
